In the last trading session, 7.17 million Moderna Inc (NASDAQ:MRNA) shares changed hands as the company’s beta touched 1.86. With the company’s per share price at $27.68 changed hands at -$0.46 or -1.63% during last session, the market valuation stood at $10.71B. MRNA’s last price was a discount, traded about -450.14% off its 52-week high of $152.28. The share price had its 52-week low at $23.15, which suggests the last value was 16.37% up since then.
Analysts gave the Moderna Inc (MRNA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.86. If we narrow down to specifics, the data shows that 2 out of 17 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 3 recommended MRNA as a Hold, 12 felt it is a Buy and 0 rated the stock as Underweight.
Moderna Inc (NASDAQ:MRNA) trade information
Instantly MRNA was in red as seen at the end of in last trading. With action -0.47%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -33.43%, with the 5-day performance at -0.47% in the red. However, in the 30-day time frame, Moderna Inc (NASDAQ:MRNA) is 14.14% up.
The consensus price target for the stock as assigned by Wall Street analysts is 47.5, meaning bulls need an upside of 41.73% from its current market value. According to analyst projections, MRNA’s forecast low is 45 with 50 as the target high. To hit the forecast high, the stock’s price needs a -80.64% plunge from its current level, while the stock would need to soar -62.57% for it to hit the projected low.
Moderna Inc (MRNA) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -42.94%. The 2025 estimates are for Moderna Inc earnings to decrease by -8.36%, but the outlook for the next 5-year period is at 20.91% per year.
Moderna Inc (NASDAQ:MRNA)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 10.3028% or 39.56 million shares worth $4.7 billion as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund. With 10.96 shares estimated at $303.4 million under it, the former controlled 2.83% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard 500 Index Fund held about 2.43% of the shares, roughly 9.41 shares worth around $260.46 million.
